A systematic review and meta-analysis of the efficacy of vonoprazan for proton pump inhibitor-resistant gastroesophageal reflux disease.

Daniel Martin SimadibrataElvira LesmanaRonnie Fass

Published in: Journal of gastroenterology and hepatology (2024)

Vonoprazan demonstrated high efficacy in the healing and maintenance of PPI-resistant EE and moderate efficacy for the improvement of FSSG score. Vonoprazan was well tolerated in PPI-resistant GERD patients.

Keyphrases

gastroesophageal reflux disease
helicobacter pylori
end stage renal disease
endoscopic submucosal dissection
ejection fraction
chronic kidney disease
newly diagnosed
prognostic factors
peritoneal dialysis
high intensity
patient reported